These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

956 related items for PubMed ID: 9484276

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The palpable breast lump: information and recommendations to assist decision-making when a breast lump is detected. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
    CMAJ; 1998 Feb 10; 158 Suppl 3():S3-8. PubMed ID: 9484272
    [Abstract] [Full Text] [Related]

  • 3. Follow-up after treatment for breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    CMAJ; 1998 Feb 10; 158 Suppl 3():S65-70. PubMed ID: 9484280
    [Abstract] [Full Text] [Related]

  • 4. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.
    Breast Cancer Res Treat; 2008 Jun 10; 109(3):405-16. PubMed ID: 17687650
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH, Tsiotou AG.
    Cancer Treat Rev; 2000 Apr 10; 26(2):103-25. PubMed ID: 10772968
    [Abstract] [Full Text] [Related]

  • 7. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
    Boyages J, Delaney G, Taylor R.
    Cancer; 1999 Feb 01; 85(3):616-28. PubMed ID: 10091735
    [Abstract] [Full Text] [Related]

  • 8. Influence of local treatment on the recurrence rate of ductal carcinoma in situ.
    Warneke J, Grossklaus D, Davis J, Stea B, Bebb G, Taylor C, Hastings R, Villar H.
    J Am Coll Surg; 1995 Jun 01; 180(6):683-8. PubMed ID: 7773481
    [Abstract] [Full Text] [Related]

  • 9. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
    Mokbel K.
    Int J Fertil Womens Med; 2003 Jun 01; 48(5):217-25. PubMed ID: 14626378
    [Abstract] [Full Text] [Related]

  • 10. Predictors of surgical margin status in breast-conserving surgery within a breast screening program.
    Kurniawan ED, Wong MH, Windle I, Rose A, Mou A, Buchanan M, Collins JP, Miller JA, Gruen RL, Mann GB.
    Ann Surg Oncol; 2008 Sep 01; 15(9):2542-9. PubMed ID: 18618180
    [Abstract] [Full Text] [Related]

  • 11. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
    Cabioglu N, Krishnamurthy S, Kuerer HM, Hunt KK, Singletary SE, Meric-Bernstam F, Ross MI, Feig BW, Ames FC, Babiera GV.
    Cancer; 2004 Aug 01; 101(3):508-17. PubMed ID: 15274063
    [Abstract] [Full Text] [Related]

  • 12. Contemporary treatment of ductal carcinoma in situ of the breast.
    Mokbel K.
    Med Sci Monit; 2005 Mar 01; 11(3):RA86-93. PubMed ID: 15735580
    [Abstract] [Full Text] [Related]

  • 13. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
    Cabioglu N, Hunt KK, Sahin AA, Kuerer HM, Babiera GV, Singletary SE, Whitman GJ, Ross MI, Ames FC, Feig BW, Buchholz TA, Meric-Bernstam F.
    Ann Surg Oncol; 2007 Apr 01; 14(4):1458-71. PubMed ID: 17260108
    [Abstract] [Full Text] [Related]

  • 14. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ.
    Dunne C, Burke JP, Morrow M, Kell MR.
    J Clin Oncol; 2009 Apr 01; 27(10):1615-20. PubMed ID: 19255332
    [Abstract] [Full Text] [Related]

  • 15. Ductal carcinoma in situ of the breast: correlation of pathologic and mammographic features with extent of disease.
    Coombs JH, Hubbard E, Hudson K, Wunderlich C, VanMeter S, Bell JL, Gwin JL.
    Am Surg; 1997 Dec 01; 63(12):1079-83. PubMed ID: 9393256
    [Abstract] [Full Text] [Related]

  • 16. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ, Symmans WF, Babiera GV, Singletary SE, Arun B, Sneige N, Pusztai L, Buchholz TA, Sahin A, Hunt KK, Meric-Bernstam F, Ross MI, Ames FC, Kuerer HM.
    Cancer; 2006 Jan 01; 106(1):42-50. PubMed ID: 16333852
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The treatment of ductal carcinoma in situ (DCIS) of the breast].
    Westenberg AH, Rutgers EJ, Peterse JL, Hendriks JH, Beex LV, van Tienhoven G.
    Ned Tijdschr Geneeskd; 2003 Nov 01; 147(44):2157-61. PubMed ID: 14626831
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.